book chapter · Advances in bioinformatics and biomedical engineering book series
Neuroinflammation is a complex, well-orchestrated process involving various groups of CNS glial cells and immune cells. Glial cells play a remarkable structural and functional role in the nervous system compared to neurons. However, neuroinflammation at the central level is a key player in various neurological disorders, including neurodegenerative diseases and CNS lesions. Therapeutic approaches to combat human neurodegenerative diseases must therefore restore neuronal and glial cell function. Natural resources are a source of potential therapeutic molecules for the treatment of neurodegenerative diseases. Currently, chitosan and its derivatives from arthropod exoskeletons are endowed with powerful anti-neuroinflammatory properties, as well as the ability to transport therapeutic substances across the BBB. This chapter discusses possible therapeutic options, the mechanism and role of chitosan in alleviating neuroinflammation at the central level, and the resulting diseases, in particular glial cell disorders.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4018/978-1-6684-9675-6.ch020
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
